Advertisement

Topics

22nd Century Receives Guidance from FDA on Phase III Clinical Trials

09:55 EDT 22 Jun 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Company plans to commence Phase III trials for “X-22” smoking cessation product in 2018 22nd Century Group, Inc. (NYSE MKT: XXII), a plant biotechnology company that is a leader in tobacco harm reduction, announce...

Other Sources for this Article

22nd Century Group
Investor Relations:
IRTH Communications
Andrew Haag, 866-976-4784
xxii@irthcommunications.com

NEXT ARTICLE

More From BioPortfolio on "22nd Century Receives Guidance from FDA on Phase III Clinical Trials"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Anesthesiology
An anesthesiologist (US English) or anaesthetist (British English) is a physician trained in anesthesia and perioperative medicine. Anesthesiologists are physicians who provide medical care to patients in a wide variety of (usually acute) situations. ...